First Choice Healthcare Solutions, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that First Choice Healthcare Solutions, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $1.05M | Mar 31, 2014 |
| FY2013 | Dec 31, 2012 | $1.16M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $1.30M | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | $1.26M | Mar 30, 2012 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $6.51M | Mar 31, 2014 |
| FY2013 | Dec 31, 2012 | $3.81M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $1.30M | Apr 1, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.4K | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $30.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $1.07M | May 13, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.96M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($3.85M) | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | ($8.17M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($9.94M) | May 13, 2024 |
| FY2017 | Dec 31, 2017 | $3.89M | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | $9.17M | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | ($3.42M) | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | ($2.49M) | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($4.70M) | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | ($873.4K) | Mar 31, 2014 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.67M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($1.29M) | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | ($2.41M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($7.02M) | May 13, 2024 |
| FY2017 | Dec 31, 2017 | ($4.41M) | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | $139.7K | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | ($1.93M) | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | ($1.54M) | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($978.2K) | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | ($277.7K) | Mar 31, 2014 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.88M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $906.8K | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $2.19M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $3.62M | May 13, 2024 |
| FY2014 | Dec 31, 2014 | $2.43M | Apr 15, 2015 |
| FY2014 | Dec 31, 2013 | $1.71M | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $1.31M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $795.7K | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | $696.9K | Mar 30, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($549.0K) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($1.71M) | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | ($6.80M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($3.38M) | May 13, 2024 |
| FY2012 | Dec 31, 2012 | ($788.9K) | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | $66.3K | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | $414.4K | Mar 30, 2012 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $82.9K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $80.7K | May 13, 2024 |
| FY2017 | Dec 31, 2017 | $330.4K | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | $254.6K | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | $206.3K | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | $145.2K | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $397.7K | Apr 15, 2015 |
| FY2012 | Dec 31, 2012 | $2.78M | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | $0 | Apr 1, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.05M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $4.51M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $3.12M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $6.52M | May 13, 2024 |
| FY2017 | Dec 31, 2017 | $18.75M | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | $22.15M | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | $22.62M | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | $11.47M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $11.81M | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $10.13M | Mar 31, 2014 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.58M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $36.98M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $31.65M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $26.92M | May 13, 2024 |
| FY2017 | Dec 31, 2017 | $7.27M | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | $7.19M | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | $19.59M | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | $14.63M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $13.60M | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $11.43M | Mar 31, 2014 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($39.53M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($32.47M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2023 | ($28.53M) | Mar 11, 2026 |
| FY2024 | Dec 31, 2022 | ($20.41M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | ($19.08M) | May 13, 2024 |
| FY2017 | Dec 31, 2017 | $10.97M | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | $13.94M | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | $2.12M | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | ($3.16M) | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($1.79M) | Apr 15, 2015 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $899.5K | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | $899.5K | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | $899.5K | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | $0 | Apr 14, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($74.74M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($67.78M) | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | ($63.93M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($55.76M) | May 13, 2024 |
| FY2017 | Dec 31, 2017 | $13.99M | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | ($10.10M) | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | ($19.27M) | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | ($15.85M) | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($13.36M) | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | ($8.66M) | Mar 31, 2014 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.9K | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $19.9K | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $12.6K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $7.2K | May 13, 2024 |
| FY2017 | Dec 31, 2017 | $2.02M | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | $4.59M | Apr 3, 2018 |
| FY2017 | Dec 31, 2015 | $1.59M | Apr 3, 2018 |
| FY2017 | Mar 31, 2015 | $112.8K | Apr 3, 2018 |
| FY2016 | Dec 31, 2014 | $279.1K | Apr 3, 2017 |
| FY2015 | Dec 31, 2013 | $739.2K | Apr 14, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $8.19M | Apr 14, 2016 |
| FY2014 | Dec 31, 2014 | $8.92M | Apr 15, 2015 |
| FY2013 | Dec 31, 2013 | $9.68M | Mar 31, 2014 |
| FY2012 | Dec 31, 2012 | $10.40M | Apr 1, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | May 13, 2024 |
| FY2017 | Dec 31, 2017 | 0 | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Apr 1, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | May 13, 2024 |
| FY2017 | Dec 31, 2017 | 0 | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 31, 2014 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 32.96M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | 32.96M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | 32.96M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 32.96M | May 13, 2024 |
| FY2017 | Dec 31, 2017 | 27.17M | Apr 3, 2018 |
| FY2017 | Dec 31, 2016 | 24.63M | Apr 3, 2018 |
| FY2016 | Dec 31, 2015 | 22.87M | Apr 3, 2017 |
| FY2015 | Dec 31, 2014 | 17.95M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | 16.75M | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | 12.71M | Mar 31, 2014 |